Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
February 14 2025 - 3:24PM
Edgar (US Regulatory)
JPMorgan Chase Financial Company LLC
Free Writing Prospectus Filed Pursuant to
Rule 433
Registration Statement Nos. 333-270004 and
333-270004-01
Dated February 14, 2025
30m
EEM Buffered PLUS
This document provides a summary of the terms of the
Buffered PLUS. Investors must carefully review the accompanying preliminary pricing supplement referenced below, product supplement, underlying
supplement, prospectus supplement, prospectus and prospectus addendum and the “Risk Considerations” on the following page,
prior to making an investment decision.
SUMMARY TERMS |
Issuer: |
JPMorgan Chase Financial Company LLC (“JPMorgan Financial”) |
Guarantor: |
JPMorgan Chase & Co. |
ETF Shares: |
Shares of the iShares® MSCI Emerging Markets ETF (Bloomberg ticker: EEM UP Equity) |
Payment at maturity: |
If the final share price is greater than the initial share price,
for each $1,000 stated principal amount Buffered PLUS,
$1,000 + leveraged upside payment
In no event will the payment at maturity exceed the maximum payment
at maturity.
If the final share price is equal to the initial share price or
is less than the initial share price but has decreased from the initial share price by an amount less than or equal to the
buffer amount of 10.00%, for each $1,000 stated principal amount Buffered PLUS,
$1,000
If the final share price is less than the initial share price
and has decreased from the initial share price by an amount greater than the buffer amount of 10.00%, for each $1,000 stated principal
amount Buffered PLUS,
($1,000 × share performance factor) + $100.00
This amount will be less than the stated principal amount of $1,000
per Buffered PLUS. |
Leveraged upside payment: |
$1,000 × leverage factor × share percent increase |
Share percent increase: |
(final share price – initial share price) / initial share price |
Initial share price: |
The closing price of one ETF Share on the pricing date |
Final share price: |
The closing price of one ETF Share on the valuation date |
Share adjustment factor: |
The share adjustment factor is referenced in determining the closing price of one ETF Share and is set initially at 1.0 on the pricing date. The share adjustment factor is subject to adjustment in the event of certain events affecting the ETF Shares. See “The Underlyings — Funds — Anti-Dilution Adjustments” in the accompanying product supplement. |
Leverage factor: |
160% |
Buffer amount: |
10.00% |
Share performance factor: |
final share price / initial share price |
Maximum payment at maturity: |
At least $1,274.00 (at least 127.40% of the stated principal amount) per Buffered PLUS |
Minimum payment at maturity: |
$100.00 per Buffered PLUS (10.00% of the stated principal amount) |
Stated principal amount: |
$1,000 per Buffered PLUS |
Issue price: |
$1,000 per Buffered PLUS |
Pricing date: |
Expected to be February 28, 2025 |
Original issue date (settlement date): |
3 business days after the pricing date |
Valuation date†: |
August 31, 2027 |
Maturity date†: |
September 3, 2027 |
CUSIP / ISIN: |
48136B6W6 / US48136B6W68 |
Preliminary pricing supplement: |
http://www.sec.gov/Archives/edgar/data/
1665650/000121390025014161/ea0231262-01_424b2.htm |
†Subject to postponement
The estimated value of the Buffered PLUS on the pricing date will be provided
in the pricing supplement and will not be less than $930.00 per $1,000 stated principal amount Buffered PLUS.
For information about the estimated value of the Buffered PLUS, which likely
will be lower than the price you paid for the Buffered PLUS, please see the hyperlink above.
Any payment on the Buffered PLUS is subject to the credit risk of JPMorgan
Financial, as issuer of the Buffered PLUS, and the credit risk of JPMorgan Chase & Co., as guarantor of the Buffered PLUS.
![](https://www.sec.gov/Archives/edgar/data/19617/000121390025014288/image_001.jpg)
Change in ETF Shares |
Return on the Buffered PLUS* |
50.000% |
27.40% |
40.000% |
27.40% |
30.000% |
27.40% |
20.000% |
27.40% |
17.125% |
27.40% |
10.000% |
16.00% |
5.000% |
8.00% |
1.000% |
1.60% |
0.000% |
0.00% |
-5.000% |
0.00% |
-10.000% |
0.00% |
-20.000% |
-10.00% |
-30.000% |
-20.00% |
-40.000% |
-30.00% |
-50.000% |
-40.00% |
-60.000% |
-50.00% |
-80.000% |
-70.00% |
-100.000% |
-90.00% |
*Assumes a maximum payment at maturity of 127.40% of the stated
principal amount
JPMorgan Chase Financial Company LLC
30m
EEM Buffered PLUS
ETF Shares
For more information about the ETF Shares,
including historical performance information, see the accompanying preliminary pricing supplement.
Risk Considerations
The risks identified below are not exhaustive. Please see “Risk Factors”
in the accompanying prospectus supplement, product supplement and preliminary pricing supplement and Annex A to the accompanying prospectus
addendum for additional information.
Risks Relating to the Buffered
PLUS Generally
| § | Buffered PLUS do not pay interest and you could lose up to 90.00% of your principal at maturity. |
| § | The appreciation potential of the Buffered PLUS is limited by the maximum payment at maturity.
|
| § | The Buffered PLUS are subject to the credit risks of JPMorgan Financial and JPMorgan Chase & Co.,
and any actual or anticipated changes to our or JPMorgan Chase & Co.’s credit ratings or credit spreads may adversely affect
the market value of the Buffered PLUS. |
| § | As a finance subsidiary, JPMorgan Financial has no independent operations and has limited assets. |
| § | Secondary trading may be limited. |
| § | The final terms and estimated valuation of the Buffered PLUS will be provided in the pricing supplement. |
| § | The tax consequences of an investment in the Buffered PLUS are uncertain. |
Risks Relating to Conflicts
of Interest
| § | Economic interests of the issuer, the guarantor, the calculation agent, the agent of the offering of
the Buffered PLUS and other affiliates of the issuer may be different from those of investors. |
| § | Hedging and trading activities by the issuer and its affiliates could potentially affect the value of
the Buffered PLUS. |
Risks Relating to the Estimated
Value and Secondary Market Prices of the Buffered PLUS
| § | The estimated value of the Buffered
PLUS will be lower than the original issue price (price to public) of the Buffered PLUS. |
| § | The estimated value of the Buffered PLUS does not represent future values of the Buffered PLUS and may
differ from others’ estimates. |
| § | The estimated value of the Buffered PLUS is derived by reference to an internal funding rate. |
| § | The value of the Buffered PLUS
as published by J.P. Morgan Securities LLC (and which may be reflected on customer account statements) may be higher than the then-current
estimated value of the Buffered PLUS for a limited time period. |
| § | Secondary market prices of the
Buffered PLUS will likely be lower than the original issue price of the Buffered PLUS. |
| § | Secondary market prices of the
Buffered PLUS will be impacted by many economic and market factors. |
Risks Relating to the ETF
Shares
| § | Investing in the Buffered PLUS
is not equivalent to investing in the ETF Shares. |
| § | Adjustments to the ETF Shares or the underlying index could adversely affect the value of the Buffered
PLUS. |
| § | There are risks associated with the ETF Shares. |
| § | The performance and market value of the ETF Shares, particularly during periods of market volatility,
may not correlate with the performance of the underlying index as well as the net asset value per ETF Share. |
| § | The Buffered PLUS are subject to risks associated with securities issued by non-U.S. companies. |
| § | The Buffered PLUS are subject to currency exchange risk. |
| § | The Buffered PLUS entail emerging markets risk. |
| § | Recent executive orders may adversely affect the performance of the ETF Shares. |
| § | Governmental legislative and regulatory actions, including sanctions, could adversely affect your investment
in the Buffered PLUS. |
| § | The anti-dilution protection for the ETF Shares is limited. |
Tax Considerations
You should review carefully the discussion in the accompanying preliminary
pricing supplement under “Additional Information about the Buffered PLUS — Tax considerations” concerning the U.S. federal
income tax consequences of an investment in the Buffered PLUS, and you should consult your tax adviser.
SEC Legend: JPMorgan Chase Financial
Company LLC and JPMorgan Chase & Co. have filed a registration statement (including a prospectus) with the SEC for any offerings to
which these materials relate. Before you invest, you should read the prospectus in that registration statement and the other documents
relating to this offering that JPMorgan Chase Financial Company LLC and JPMorgan Chase & Co. has filed with the SEC for more complete
information about JPMorgan Chase Financial Company LLC and JPMorgan Chase & Co. and this offering. You may get these documents without
cost by visiting EDGAR on the SEC web site at www.sec.gov. Alternatively, JPMorgan Chase Financial Company LLC and JPMorgan Chase &
Co., any agent or any dealer participating in this offering will arrange to send you the prospectus and each prospectus supplement as
well as any product supplement, underlying supplement and preliminary pricing supplement if you so request by calling toll-free 1-866-535-9248.
Alerian Mlp Index ETNs d... (AMEX:AMJB)
Historical Stock Chart
From Jan 2025 to Feb 2025
Alerian Mlp Index ETNs d... (AMEX:AMJB)
Historical Stock Chart
From Feb 2024 to Feb 2025